Ads
related to: novartis- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Long-Acting HIV Treatment
An Injection Just Every Other Month
With A Flexible Treatment Window.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- Important Safety Info
Learn About Possible Side Effects
And View Important Safety Info.
- Helpful Resources
Learn About An HIV Treatment
And Discover More About Dosing.
- Treatment Costs & Savings
Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 hour agoAt BIO 2024 International Convention, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with
US judge orders probe of Novartis $30 mln settlement claims process
Reuters· 8 hours agoA federal judge has ordered a probe of the claims distribution process in a $30 million settlement...
Why Novartis (NVS) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 11 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters via Yahoo News· 18 hours agoROME (Reuters) -Italy's antitrust regulator said on Thursday it had launched an investigation into...
Pharmaceutical Giant Cencora Confirms Patient Data Breach Impacting over a Dozen Pharma Companies -...
CPO Magazine· 7 days agoU.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive...
Novartis, Roche, Biogen and Samsung Bioepis in Italy Eye-Medicine Probe
Morningstar· 14 hours agoItaly's competition watchdog is investigating four pharmaceutical companies over what it called coordination of their commercial strategies, allegedly delaying access to a biosimilar eye-disease ...
Earnings call: Novartis outlines strong forecast for Scemblix in CML treatment
Investing.com· 2 days agoNovartis has projected robust sales for its new chronic myeloid leukemia (CML) treatment, Scemblix,...
Ultra-Rich Families Fuel $20 Billion Private Equity Buyout Wave
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Ultra-rich individuals and families worth more than $150 billion are helping drive a...
Germany’s ITM raises $205M as radiopharma field booms
BioPharma Dive via Yahoo Finance· 17 hours agoAnd hundreds of millions of dollars in investment have flown into new startups. Steffen Schuster,...
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive via Yahoo Finance· 7 days agoThe results are from a late-stage clinical trial run by Scemblix’s maker, Novartis, and will be...